feed,title,long_url,short_url
Benzinga,Immunic Stock Is Trading Lower After Equity Raise Of $45M To Fund Lead Pipeline Candidates,https://benzinga.com/general/biotech/21/07/21998514/immunic-stock-is-trading-lower-after-equity-raise-of-45m-to-fund-lead-pipeline-candidates,https://j.mp/3B48Xit
Benzinga,BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder,https://benzinga.com/general/biotech/21/07/21998209/biocryst-outlines-pivotal-trial-designs-for-bcx9930-in-rare-blood-disorder,https://j.mp/2UhHeu5
